Clinical trial
Efficacy and Safety Study of Protein C Concentrate in Subjects With Severe…
NCT00157118 · Baxalta now part of Shire, Industry · Completed
Key facts
| NCT number | NCT00157118 |
|---|---|
| Title | Efficacy and Safety Study of Protein C Concentrate in Subjects With Severe Congenital Protein C Deficiency |
| Official title | A Phase II/III Clinical Study for the Determination of the Efficacy and Safety of Protein C Concentrate in Subjects With Severe Congenital Protein C Deficiency |
| Lead sponsor | Baxalta now part of Shire, Industry |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Protein C Deficiency |
| Intervention type | Drug |
| Interventions | Protein C Concentrate (Human) Vapor Heated |
| Enrollment | 18 |
| Start date | Aug 22, 2003 |
| Primary completion | Mar 17, 2005 |
| Completion | Mar 17, 2005 |
| First posted | Sep 12, 2005 |
| Last update posted | May 5, 2021 |
| Countries | United States |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: